rs746972765
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001613.4(ACTA2):c.593G>A(p.Arg198His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
ACTA2
NM_001613.4 missense
NM_001613.4 missense
Scores
9
7
2
Clinical Significance
Conservation
PhyloP100: 7.86
Genes affected
ACTA2 (HGNC:130): (actin alpha 2, smooth muscle) This gene encodes one of six different actin proteins. Actins are highly conserved proteins that are involved in cell motility, structure, integrity, and intercellular signaling. The encoded protein is a smooth muscle actin that is involved in vascular contractility and blood pressure homeostasis. Mutations in this gene cause a variety of vascular diseases, such as thoracic aortic disease, coronary artery disease, stroke, and Moyamoya disease, as well as multisystemic smooth muscle dysfunction syndrome. [provided by RefSeq, Sep 2017]
STAMBPL1 (HGNC:24105): (STAM binding protein like 1) Predicted to enable Lys63-specific deubiquitinase activity and thiol-dependent deubiquitinase. Predicted to be involved in protein K63-linked deubiquitination. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ACTA2. . Trascript score misZ 4.6117 (greater than threshold 3.09). GenCC has associacion of gene with familial thoracic aortic aneurysm and aortic dissection, connective tissue disorder, aortic aneurysm, familial thoracic 6, multisystemic smooth muscle dysfunction syndrome, Moyamoya disease 5.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.918
PP5
Variant 10-88941252-C-T is Pathogenic according to our data. Variant chr10-88941252-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 264311.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTA2 | NM_001613.4 | c.593G>A | p.Arg198His | missense_variant | 6/9 | ENST00000224784.10 | NP_001604.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTA2 | ENST00000224784.10 | c.593G>A | p.Arg198His | missense_variant | 6/9 | 1 | NM_001613.4 | ENSP00000224784.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 13, 2019 | The p.Arg198His variant in ACTA2 has been reported in at least 6 individuals with aortic aneurysms or dissections and segregated with disease in 5 affected family members (Regalado 2015; Color Genomics personal communication). It was absent from large population studies. This variant has also been reported in ClinVar (Variation ID 264311). Additionally, a different variant at this codon (p.Arg198Cys) has been reported in 2 individuals with aortic aneurysms or dissections (Regalado 2015). Computational prediction tools and conservation analysis suggest that the p.Arg198His variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal dominant familial thoracic aortic aneurysm and dissection (FTAAD). ACMG/AMP criteria applied: PM2, PS4_Moderate, PP1_Moderate, PP3. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 19, 2019 | The p.R198H variant (also known as c.593G>A), located in coding exon 5 of the ACTA2 gene, results from a G to A substitution at nucleotide position 593. The arginine at codon 198 is replaced by histidine, an amino acid with highly similar properties. In one family, this variant was described in three heterozygous individuals, two of whom were reported to have had aortic dissection and/or surgical repair of aortic aneurysm (Regalado ES et al, Circ Cardiovasc Genet 2015 Jun; 8(3):457-64). In the same study, an alteration affecting the same codon (c.592C>T p.R198C) was described in two unrelated heterozygous individuals, both of whom had dissection and/or surgical repair of aortic aneurysm. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Mar 11, 2020 | This missense variant replaces arginine with histidine at codon 198 of the ACTA2 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in multiple individuals affected with and/or having family history of aortic dissections or aneurysms (PMID: 25759435 and Color internal data). A different variant at this position (p.Arg198Cys) has also been observed in individuals affected with aortic events (PMID: 25759435). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Although additional studies are required to fully establish its clinical significance, this variant is classified as Likely Pathogenic based on the available evidence. - |
Aortic aneurysm, familial thoracic 6;C3151201:Multisystemic smooth muscle dysfunction syndrome;C3279690:Moyamoya disease 5 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM2_Supporting+PP3_Moderate+PP2+PP4+PP1 - |
Aortic aneurysm, familial thoracic 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg198 amino acid residue in ACTA2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 25759435; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ACTA2 protein function. ClinVar contains an entry for this variant (Variation ID: 264311). This missense change has been observed in individuals with aneurysm and/or dissection (PMID: 25759435; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 198 of the ACTA2 protein (p.Arg198His). - |
not provided Uncertain:1
Uncertain significance, flagged submission | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Dec 16, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift4G
Uncertain
D
Polyphen
B
Vest4
MutPred
Loss of phosphorylation at T196 (P = 0.0878);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at